Improved functioning in a woman with schizophrenia on exclusive therapy with oestrogen pills

Australasian Psychiatry

Volumn 10, Issue 4, 2002, Pages 403-404

  Tunde Ayinmode, Mosunmola ^a   Singh, Ashok Kumar ^a   Marsden, Karen ^a  

^a BALLARAT HEALTH SERVICES   (Australia)

Author keywords

Oestrogen therapy; Schizophrenia

Indexed keywords

ETHINYLESTRADIOL PLUS NORETHISTERONE; NEUROLEPTIC AGENT; ORAL CONTRACEPTIVE AGENT; ZUCLOPENTHIXOL DECANOATE;

ADULT; ARTICLE; CASE REPORT; CHRONIC DISEASE; CLINICAL FEATURE; DELUSION; DISEASE DURATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG TOLERABILITY; ESTROGEN THERAPY; FAMILY; FEMALE; HUMAN; MENTAL DISEASE; MENTAL FUNCTION; MONOTHERAPY; PARANOID SCHIZOPHRENIA; PATIENT ATTITUDE; PATIENT COMPLIANCE; PILL; SIDE EFFECT; SOCIAL DISABILITY; SOCIAL STATUS; SYMPTOM; THOUGHT DISORDER;

EID: 0036915168     PISSN: 10398562     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1665.2002.00504.x     Document Type: Article

References (11)

1. Cyr M, Calon F, Morissette M, Grandbois M, Di Paolo T, Callier S. Drugs with oestrogen-like potency and brain activity: Potential therapeutic application for CNS. Current Pharmaceutical Design 2000; 6: 1287-1312.
2. Morrison MF, Tweedy K. Effects of oestrogen on mood and cognition in aging women. Psychiatric Annals 2000; 30: 113-119.
3. Kulkarni J, De Castella A, Smith D, Taffe J, Keks N, Copolov D. A clinical trial of the effects of oestrogen in acutely psychotic women. Schizophrenia Research 1996; 20: 247-252.
4. Pearlstein TB. Hormones and depression: What are the facts about premenstrual syndrome, menopause and hormone replacement therapy? American Journal of Obstetrics and Gynaecology 1995; 173: 646-653.
5. Watt DC, Katz K, Shepherd M. The natural history of schizophrenia: A 5-year prospective follow-up of a representative sample of schizophrenics by means of a standardized clinical and social assessment. Psychological Medicine 1983; 13: 663-670.
6. Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A, Geisler S, Chakos M, Koreen A, Jody D, Kane J, Woerner M, Cooper T. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. American Journal of Psychiatry 1995; 152: 698-703.
7. Seeman MV. Current outcome in schizophrenia: Women vs men. Acta Psychiatrica Scandinavica 1986; 73: 609-617.
8. Seeman MV. Gender differences in Schizophrenia. Canadian Journal of Psychiatry. 1982; 27: 107-112.
9. Seeman MV. The role of oestrogen in schizophrenia. Journal of Psychiatry and Neuroscience 1996; 21: 123-127.
10. Kulkarni J. Women and schizophrenia: A review. Australia New Zealand Journal of Psychiatry 1997; 31: 46-56.
11. Brace M, McCauley E. Oestrogen and psychological well being. Annals of Medicine 1997; 29: 283-290.